Rong Xu, PhD is the professor of biomedical informatics, and director of the Center for AI in Drug Discovery at Case Western Reserve University School of Medicine in Cleveland, Ohio.
The new weight loss drugs are called glucagon-like peptide-1 receptor agonists (GLP-1RA). The first drug, exenatide (Byetta), was approved to treat type 2 diabetes (T2D)...
